Spots Global Cancer Trial Database for Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Official Title: Metabolic Profiling of Peripheral Blood Mononuclear Cells (PBMCs) by LC-MS in Prostate Cancer Patients

Study ID: NCT03485794

Conditions

Prostate Carcinoma

Interventions

Biospecimen Collection

Laboratory Biomarker Analysis

Study Description

Brief Summary: This pilot research trial utilizes the collection of blood in studying metabolites in patients with prostate cancer. Metabolites are the small molecule products of cellular metabolism that are produced naturally in all living cells. Collecting blood in order to study metabolites may help doctors monitor and treat prostate cancer more effectively.

Detailed Description: PRIMARY OBJECTIVES: I. Develop blood sample collection and preparation procedures for reliable, meaningful metabolomic profiling of peripheral blood mononuclear cells (PBMCs) by liquid chromatography/quadruple-time of flight/mass spectrometry (LC/Q-TOF/MS) that can be implemented in a clinical setting. II. Optimize data analysis methods and software usage to create a metabolic profile for patients at the time of blood collection. III. Compare metabolite profiles of isolated PBMCs versus (vs.) other blood fractions (plasma, red blood cells \[RBCs\], and whole blood). IV. Identify elements of the PBMC metabolite profile that may correlate to patient disease state. OUTLINE: Patients undergo collection of blood for metabolic profiling via LC/Q-TOF/MS.